Adage Capital Partners’s Soleno Therapeutics SLNO Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $300M | Sell |
3,575,964
-816,732
| -19% | -$68.4M | 0.5% | 28 |
|
|
2025
Q1 | $314M | Buy |
4,392,696
+1,616,720
| +58% | +$116M | 0.58% | 27 |
|
|
2024
Q4 | $125M | Sell |
2,775,976
-546,170
| -16% | -$24.6M | 0.22% | 87 |
|
|
2024
Q3 | $168M | Buy |
3,322,146
+468,052
| +16% | +$23.6M | 0.3% | 58 |
|
|
2024
Q2 | $116M | Buy |
2,854,094
+910,574
| +47% | +$37.2M | 0.22% | 89 |
|
|
2024
Q1 | $83.2M | Buy |
1,943,520
+116,706
| +6% | +$5M | 0.16% | 133 |
|
|
2023
Q4 | $73.5M | Buy |
1,826,814
+499,814
| +38% | +$20.1M | 0.15% | 147 |
|
|
2023
Q3 | $39.2M | Buy |
+1,327,000
| New | +$39.2M | 0.09% | 241 |
|